Condition: ST Elevation Myocardial Infarction · C-Reactive Protein · Apheresis · Sponsor: Medical University Innsbruck
Background: In patients with acute ST-elevation myocardial infarction (STEMI), the amount of infarcted myocardium (infarct size) is known to be a major predictor for adverse remodeling and recurrent adverse cardiovascular events. Effective cardio-protective strategies with the aim of reducing infarct size are therefore of great interest. Local and systemic inflammation influences the fate of ischemic myocardium and thus, adverse remodeling and clinical outcome. C-reactive protein (CRP) also acts as a potential mechanistic mediator that adversely affects the amount of irreversible myocardial tissue damage after acute myocardial infarction. Objective: The main objectives of the current study are to investigate the efficacy of selective CRP apheresis, using the PentraSorb®-CRP system, as an adjunctive therapy to standard of care for patients with acute STEMI treated with primary PCI. Design: Investigator-initiated, prospective, randomized, open-label (outcome assessors masked), controlled, multicenter, two group trial with a two-stage adaptive design. Innovation: Selective CRP apheresis offers potential to decrease infarct size and consequently improve outcome after PCI for STEMI. This is the first randomized trial investigating the impact of selective CRP apheresis on infarct size in post-STEMI patients. In perspective, the study design allows furthermore to collect robust evidence for the design of a definitive outcome study.
This description comes directly from the study's public registry record.
Sebastian J Reinstadler, MD, PhD · +43 (0) 512 504 25665 · sebastian.reinstadler@gmail.com
Ivan Lechner, MD, PhD · +43 (0) 512 504 25665 · ivan.lechner@tirol-kliniken.at
Always discuss trial participation with your own doctor first.
| University Clinic for Cardiology and Nephrology, Medical University of Graz | Graz, Austria | Recruiting |
| University Clinic of Internal Medicine III, Cardiology and Angiology. University Clinic of Internal Medicine IV, Nephrology and Hypertensiology. University Clinic of Radiology. | Innsbruck, Austria | Recruiting |
| University Clinic of Internal Medicine II, Paracelsus Medical University Salzburg | Salzburg, Austria | Not Yet Recruiting |
| Medical Clinic II - University Heart Center Lübeck | Lübeck, Schleswig-Holstein, Germany | Not Yet Recruiting |
| Leipzig Heart Center | Leipzig, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04939805